COMPASS Pathways plc

NasdaqGS:CMPS Stok Raporu

Piyasa değeri: US$424.7m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

COMPASS Pathways Yönetim

Yönetim kriter kontrolleri 4/4

COMPASS Pathways' CEO'su Kabir Nath, Aug2022 tarihinde atandı, in görev süresi 2.17 yıldır. in toplam yıllık tazminatı $ 2.82M olup, şirket hissesi ve opsiyonları dahil olmak üzere 21% maaş ve 79% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.037% ine doğrudan sahiptir ve bu hisseler $ 158.34K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.2 yıl ve 4.1 yıldır.

Anahtar bilgiler

Kabir Nath

İcra Kurulu Başkanı

US$2.8m

Toplam tazminat

CEO maaş yüzdesi21.0%
CEO görev süresi2.2yrs
CEO sahipliği0.04%
Yönetim ortalama görev süresi2.2yrs
Yönetim Kurulu ortalama görev süresi4.1yrs

Son yönetim güncellemeleri

Recent updates

Compass Pathways: Sector-Wide Reality Check Needed Post FDA Lykos MDMA Decision

Aug 19

Compass Pathways: Buy It For Its Promising Psychedelic Mental Health Therapies

Jul 08

Psychedelics Closer To Commercialization; Compass Far And Away The Leader

May 23

COMPASS Pathways: Will MDMA-Assisted Therapy Pave The Way Or Slam The Door Shut?

Apr 25

Compass Pathways: Psilocybin Developer A Potentially Intriguing, Contrarian Play

Feb 08

Companies Like COMPASS Pathways (NASDAQ:CMPS) Are In A Position To Invest In Growth

Dec 06
Companies Like COMPASS Pathways (NASDAQ:CMPS) Are In A Position To Invest In Growth

Booker again pushes for easier access to psychedelics for terminally ill patients

Oct 19

Here's Why We're Not Too Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Situation

Aug 13
Here's Why We're Not Too Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Situation

COMPASS Pathways And The Trillion Dollar Opportunity

Aug 11

COMPASS Pathways ADS Q2 2022 Earnings Preview

Aug 03

COMPASS Pathways names new CEO

Jul 19

Compass Pathways: Shares Look Cheap But Proving Psilocybin Case Won't Be Easy

Jun 30

We're Hopeful That COMPASS Pathways (NASDAQ:CMPS) Will Use Its Cash Wisely

Apr 28
We're Hopeful That COMPASS Pathways (NASDAQ:CMPS) Will Use Its Cash Wisely

Checking In On Compass Pathways

Mar 02

We Think COMPASS Pathways (NASDAQ:CMPS) Can Afford To Drive Business Growth

Dec 29
We Think COMPASS Pathways (NASDAQ:CMPS) Can Afford To Drive Business Growth

Compass Pathways: Psychedelics For Mental Health

Nov 23

Compass Faces Tricky Road To Approval For Its Psychedelic Depressive Therapy

Sep 17

COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans

Sep 15
COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans

Compass Pathways: Huge Growth Potential, But I'm Cautious

Jun 04

COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans

May 25
COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans

COMPASS Pathways raises $144M capital via equity offering

Apr 30

COMPASS Pathways launches public offering

Apr 27

We're Not Very Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Rate

Feb 08
We're Not Very Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Rate

Psilocybin Will Change Mental Health, Compass Pathways Could Be At The Forefront

Jan 01

Compass Pathways: Risky And Overvalued

Dec 18

What Type Of Shareholders Make Up COMPASS Pathways plc's (NASDAQ:CMPS) Share Registry?

Dec 18
What Type Of Shareholders Make Up COMPASS Pathways plc's (NASDAQ:CMPS) Share Registry?

COMPASS Pathways: Risky But Can Pay Back Generously

Dec 14

Compass Pathways: An Overvalued Psychedelic Company With A Single Mediocre Drug

Nov 23

COMPASS Pathways ADS reports Q3 results

Nov 12

CEO Tazminat Analizi

Kabir Nath'un ücretlendirmesi COMPASS Pathways'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$139m

Mar 31 2024n/an/a

-US$129m

Dec 31 2023US$3mUS$595k

-US$118m

Sep 30 2023n/an/a

-US$117m

Jun 30 2023n/an/a

-US$102m

Mar 31 2023n/an/a

-US$95m

Dec 31 2022US$8mUS$243k

-US$92m

Tazminat ve Piyasa: Kabir 'ın toplam tazminatı ($USD 2.82M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 2.40M ).

Tazminat ve Kazançlar: Kabir 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.


CEO

Kabir Nath (60 yo)

2.2yrs

Görev süresi

US$2,824,758

Tazminat

Mr. Kabir Kumar Nath M. A., M. B.A., is Chief Executive Officer and Director of COMPASS Pathways plc from August 1, 2022. He serves as President & CEO at Otsuka America Pharmaceutical, Inc. He served as Pr...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Kabir Nath
CEO & Director2.2yrsUS$2.82m0.037%
$ 156.1k
Matthew Owens
General Counsel & Chief Legal Officer2.7yrsUS$1.32m0.0059%
$ 25.1k
Guy Goodwin
Chief Medical Officer3.3yrsUS$1.20m0.0029%
$ 12.4k
Teri Loxam
CFO, Principal Financial Officer & Principal Accounting Officerless than a yearVeri yokVeri yok
Greg Ryslik
Chief Technology Officer2.8yrsVeri yokVeri yok
Stephen Schultz
Senior Vice President of Investor Relationsno dataVeri yokVeri yok
Christopher Williams
Chief Communications Officer2yrsVeri yokVeri yok
Anne Benedict
Chief People Officerno dataVeri yokVeri yok
Lars Wilde
Senior Advisor2.8yrsVeri yokVeri yok
Susan Stansfield
Advisorno dataVeri yokVeri yok
Michael Gold
Chief Research & Development Officerless than a yearVeri yokVeri yok
Lori Englebert
Chief Commercial Officerless than a yearVeri yokVeri yok

2.2yrs

Ortalama Görev Süresi

51yo

Ortalama Yaş

Deneyimli Yönetim: CMPS 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.2 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Kabir Nath
CEO & Director2.2yrsUS$2.82m0.037%
$ 156.1k
Alan Schatzberg
Member of Scientific Advisory Networkno dataVeri yokVeri yok
Linda McGoldrick
Independent Non Executive Director4.1yrsUS$209.48k0%
$ 0
Gino Santini
Chairmanless than a yearVeri yokVeri yok
David Norton
Independent Director6.4yrsUS$215.57k0.025%
$ 108.0k
Daphne Karydas
Independent Director1.1yrsUS$363.71k0%
$ 0
Robert McQuade
Independent Non Executive Director4.5yrsUS$210.84k0%
$ 0
Wayne Riley
Independent Non-Executive Director3.6yrsUS$200.86k0%
$ 0
Thomas Lonngren
Independent Non-Executive Director6.4yrsUS$199.82k0.13%
$ 553.0k
Annalisa Lisa Jenkins
Independent Non-Executive Director6.4yrsUS$214.78k0.051%
$ 216.6k
Diego Pizzagalli
Member of Scientific Advisory Networkno dataVeri yokVeri yok
Gul Dolen
Member of Scientific Advisory Networkno dataVeri yokVeri yok

4.1yrs

Ortalama Görev Süresi

67yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: CMPS 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.1 yıldır).